Atlas Trials

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

Clinical trial NCT01188512 · COMPLETED

Trial details

NCT number
NCT01188512
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pertussis
Start date
2010-08-01
Primary completion
2011-06-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.